In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
TT Smith, SB Stephan, HF Moffett, LE McKnight… - Nature …, 2017 - nature.com
An emerging approach for treating cancer involves programming patient-derived T cells with
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
[PDF][PDF] In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
TT Smith, SB Stephan, HF Moffett, LE McKnight… - Nat …, 2017 - researchgate.net
An emerging approach for treating cancer involves programming patient-derived T cells with
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.
TT Smith, SB Stephan, HF Moffett… - Nature …, 2017 - europepmc.org
An emerging approach for treating cancer involves programming patient-derived T cells with
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
[HTML][HTML] In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
TT Smith, SB Stephan, HF Moffett… - Nature …, 2017 - ncbi.nlm.nih.gov
An emerging approach for treating cancer involves programming patient-derived T cells with
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
[引用][C] In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
TT Smith, SB Stephan, HF Moffett, LE McKnight… - Nature …, 2017 - cir.nii.ac.jp
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
TT Smith, SB Stephan, HF Moffett… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
An emerging approach for treating cancer involves programming patient-derived T cells with
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.
TT Smith, SB Stephan, HF Moffett… - Nature …, 2017 - europepmc.org
An emerging approach for treating cancer involves programming patient-derived T cells with
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …
genes encoding disease-specific chimeric antigen receptors (CARs), so that they can …